ment the rules and regulations for the preservation of drugs, and measures should be taken to control the temperature and humidity, and to avoid insects and rodents.
An inspection system should be implemented when drugs are added to or cleared from the stock.
Article 15 The sale of herbal drugs on the market of country fairs is permitted with certain exceptions.
The sale of drugs other than herbal drugs on the market of country fairs is prohibited unless the dealer is the holder of a "drug handler certificate".
GHAPTER N
DRUG CONTROL IN
MEDICAL UNITS
Article 16 Medical units should be staffed with pharma- ceutical technicians adaptable to their speciality, and non- pharmaceutical personnel should not be directly engaged in pharmaceutical work.
Article 17 The dispensing of pharmaceutical preparations in medical units should be sanctioned by the health bureau of relevant province, autonomous region or municipality. A "drug dispensing certificate" will be issued on approval. A date of expiration should be fixed for each "drug dis- pensing certificate", and an application for the renewal of
-32-
a certificate should be submitted before it expires. Relevant regulations of the certification procedure will be stipulated by the Ministry of Public Health.
Article 18 In order to guarantee the quality of drugs, any medical unit dispensing pharmaceutical preparations should be adequately equipped with dispensing facilities and analytical instruments, and a suitable hygienic environment.
Article 19 Pharmaceutical preparations dispensed by medical units should be examined on the basis of clinical necessity and established standards, can only be used when they are up to standard and prescribed by a doctor.
Pharmaceutical preparations dispensed by medical units should not be sold on the market.
Article 20 The quality of drugs purchased by medical units should be examined upon receiving.
CHAPTER
▼
THE CONTROL OF DRUGS
Article 21 The State encourages the research and deve- lopment of new drugs.
The clinical trial or clinical verification of a new
drug should be sanctioned by the Ministry of Public Health or the health bureau of province, autonomous region or cipality. An application for the clinical trial of a new drug
-33-
muni-